Emmanuel Volanakis, M.D., assistant professor of Pediatrics and Hematology/Oncology, was awarded a $250,000 Hyundai Hope On Wheels grant last week for his ongoing research into T-cell acute lymphoblastic leukemia (ALL), an aggressive blood cancer.

Over the past decade, neurointerventionalists have refined techniques for manually removing blood clots causing stroke. Now they are joining forces for a clinical trial to demonstrate the safety and effectiveness of the techniques.

Vanderbilt University investigators for the first time have linked a non-inherited, de novo mutation in the dopamine transporter to autism spectrum disorder (ASD).

Vanderbilt University's latest offering on the online learning platform Coursera, "Data Management for Clinical Research," went live this week. More than 33,000 number of students have registered for the massive open online course or MOOC.

Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.

Researchers at the Vanderbilt Heart and Vascular Institute and Massachusetts General Hospital have identified a biomarker that can predict diabetes risk up to 10 years before onset of the disease.

New mass spectrometry imaging methods will enable studies of the distribution and identification of membrane proteins directly within tissues.